Introduction In many ways, healthcare is an industry built and sustained by women. According to the WHO, women account for around two-thirds (67%) of the
Introduction During 2023, we have seen revisions to pharmaceutical legislation, countdown to Jan 2025 and the EU Joint Clinical Assessment, patient experience data on the
By: Sophie Schmitz, Akshay Kumar, Joanna Fernandes, Chloe Sheppard, Srishti Gupta, Andrea Bernardini, Fisentzos Stylianou, Olivia Johns, Priyanka Kiritharan & Jodie Lyons Introduction In 2022
By: Sophie Schmitz, Akshay Kumar, Richard Wang, Fisentzos Stylianou, Adama Anozie, Chloe Sheppard, Nadia Al Lahiq, Andrea Bernardini & Sylwia Lach Introduction 2021 saw the
By: Richard Wang, Adama Anozie Akshay Kumar & Bruce Chin What is Hospital Exemption? In recent years, we have seen rapid commercial development of advanced
In January 2018, the European Commission released a legislative proposal on Health Technology Assessment (HTA) with the overarching goal to strengthen cooperation among national HTA
Why embrace them? By Chloe Sheppard, Erfan Akbraian, Andrea Bernardini & Richard Wang Advanced Therapy Medicinal Products (ATMPs) have significant potential to transform the lives
Are they as beneficial to manufacturers as they seem? By Joana Fernandes & Ashkay Kumar What are the research aims? Products that are being reviewed
Are they right for your therapy? By Maximus Rex & Nicola Allen Drug development is a long and costly process. It is not uncommon for
